The CDC is usually the one to lead the way on making sure Americans are up to date on their vaccines. But funding cuts, political turmoil and concerns about scientific independence within the nation’s...

Covid-19 shot makers have not been working closely with the CDC’s vaccine advisors and aren’t expected to make substantive presentations to the panel when it convenes later this week, multiple sources...

The National Cancer Institute said it will stop funding a 26-year-old collaboration with academic centers to help accelerate new pediatric brain tumor treatments.

Some of the studies that underpin the Trump administration’s decision to veer away from mRNA vaccine research are being misapplied, co-authors of the work say, muddling the move by HHS and Secretary R...

Some of the studies that underpin the Trump administration’s decision to veer away from mRNA vaccine research are being misapplied, co-authors of the work say, muddling the move by HHS and Secretary R...

Gray Delany, head of MAHA implementation at HHS, has been fired from his government role, according to a source familiar with the decision.

Novavax says conducting a post-marketing study for its Covid-19 vaccine will cost between $70 million and $90 million, following the FDA's more stringent approval framework that strongly advised the c...

CBER chief Prasad overrides reviewers, approves Moderna's Covid shot only for at-risk kids 6mo-11yrs, marking his third override of review team recommendations.

CBER chief Prasad overrides reviewers, approves Moderna's Covid shot only for at-risk kids 6mo-11yrs, marking his third override of review team recommendations.

Nearly 1 in 3 American adolescents have prediabetes, a CDC report finds. An official notes "it’s not too late to change course."

ACIP approved the following recommendations by majority vote and were adopted by the CDC Director.

CBER director Vinay Prasad says the benefits of Covid-19 vaccination have depreciated and may no longer outweigh the risks in adults who aren’t prone to more severe illness.

Clinicians and infectious disease specialists clashed with the majority of the CDC’s remade vaccine advisory committee on Thursday, arguing that the panel’s debate over an ingredient in a small number...

A newly rebuilt CDC vaccine advisory panel will meet for the first time this week, informing whether America's public health agency will continue to back data and evidence that have long guided its im...

HHS Secretary Robert F. Kennedy Jr. announced the move in a Wall Street Journal op-ed, citing conflict of interest concerns.

Sinema has backed a bill advancing in the Arizona legislature that would include a $5 million grant to a neurological institute to conduct a clinical study into ibogaine.

Summit Therapeutics' ivonescimab shows 48% PFS benefit but misses OS endpoint in Phase 3 lung cancer trial; drug's regulatory future unclear after mixed EGFR+ NSCLC results.

The US’ stance on Covid-19 vaccines under HHS chief Robert F. Kennedy Jr. is coming into focus with a new approval framework, new immunization guidance and, more broadly, a new attitude about the vacc...

Compass awaits Phase 3 COMP360 trial results for treatment-resistant depression amid renewed optimism for psychedelics.

The White House released its first MAHA Commission report, detailing some of the Trump administration’s top priorities for revamping the US healthcare system and issuing a “call to action.”

FDA chief Marty Makary and new CBER Director Vinay Prasad said that future Covid-19 vaccine approvals will focus on adults over 65 and high-risk people 6 months to 64 years ...

HHS Secretary Kennedy adopts CDC advisors' chikungunya vaccine guidance for Bavarian Nordic's shot, while RSV vaccine recommendations remain pending. Valneva's vaccine still approved for 18+.

President Trump met with pharma CEOs at the White House. After praising investments, a 'most favored nation' drug pricing plan has sparked industry alarm.

President Trump met with pharma CEOs at the White House. After praising investments, a 'most favored nation' drug pricing plan has sparked industry alarm.

We’re taking Post Hoc — our newsletter that brings you insight from our journalists — and streaming it live! Our plan is to talk about how the drug industry is reacting to the Trump administration’s ...

Live stream podcast tomorrow at 12pm ET with Drew Armstrong, Max Bayer & Anna Brown discussing pharma industry's response to Trump administration tariffs, including lobbying & manufacturing changes.

Decades ago, diseases like polio and measles brought suffering and death with no defense. Today, immunization represents the right and the ability to defend and protect those we love.

The FDA has asked Novavax to commit to producing post-marketing data of its Covid vaccine, the clearest example yet that the bar is higher for advancing new vaccines under HHS Secretary Robert F. Kenn...

The 340B drug discount program may move under the purview of CMS, according to a leaked HHS restructuring document reviewed by Endpoints News.

A CDC advisory panel voted to recommend RSV vaccines for at-risk adults 50 to 59, a sought-after expansion by vaccine makers who are trying to grow the market.

Tariffs on pharmaceutical products that President Donald Trump has teased for weeks are one step closer to fruition after the Department of Commerce confirmed it's launched an investigation into the s...

A panel of experts who decide the national immunization schedule will meet on Tuesday for the first time in 2025, providing an opportunity for the nation’s top vaccine scientists to publicly discuss t...

Lawfare is now accepting Summer 2025 internship applications.

Johan Luthman has been running R&D at Lundbeck since 2019, and part of the neuroscience leader’s remit is helping steer development of a promising but still-experimental seizure medication that the co...

HHS Secretary Kennedy declines Senate panel appearance to discuss agency restructuring. Cassidy and Sanders had invited him to April 10 hearing amid FDA layoffs and HHS reorganization plans.

The FDA is being consolidated into five “shared services offices,” according to a memo from HHS distributed to staff on Capitol Hill that was reviewed by Endpoints News.

BIO CEO John Crowley sat down for an exclusive interview that covered tariffs, collaborating with RFK Jr., and investing in domestic biomanufacturing.

The size and scope of the FDA that began Tuesday won’t be the same as the day nears a brutal conclusion for agency staffers that were laid off or forced to resign.

Transcend Therapeutics’ PTSD treatment succeeded in a mid-stage study, propelling the scrappy company of less than 20 people toward a Phase 3 study that could begin at the start of next year.

Lykos Therapeutics’ interim CEO Michael Mullette is planning to step down, according to a source familiar with the decision.

Termination ‘a waste of the money we’ve spent already’

HHS announces major downsizing, cutting 20,000 jobs total across FDA, CDC, and NIH. New Administration for Healthy America to be formed under Sec. Kennedy's reorganization plan.